Bill Detail
H.R. 661
Congress: 119
Title
MIRACLE Medical Technology Act of 2025
Summary
Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025 This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.
Sponsor
Rep. Vern Buchanan [R-FL-16]
Status
Referred to the House Committee on Energy and Commerce.
Status as of Jun 29, 2:24 PM · synced 6h ago
Introduced
2025-01-23
Data source mode: cache
Bill Engagement
Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025 This bill requi…
Lobbyists on the case
- Chamber of Commerce of the U.s.a.4 filings · 70 lobs
- Neil Bradley2025 Q4
- Suzanne Clark2025 Q4
- Kevin Courtois2025 Q4
- Christopher Crenshaw2025 Q4
- Nicholas Crocker2025 Q4
- Rodney Davis2025 Q4
- Erin Delaney2025 Q4
- Martin Durbin2025 Q4